Loading...

Effect of the CYP3A inhibitors, diltiazem and ketoconazole, on ticagrelor pharmacokinetics in healthy volunteers

OBJECTIVES: Two open-label, two-period, crossover studies in healthy volunteers were designed to determine the pharmacokinetic interactions between ticagrelor, a P2Y(12) receptor antagonist, and a moderate (diltiazem) and a strong (ketoconazole) cytochrome P450 (CYP) 3A inhibitor. METHODS: Seventeen...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Drug Assess
Main Authors: Teng, Renli, Butler, Kathleen
Format: Artigo
Sprog:Inglês
Udgivet: Maney Publishing 2013
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4937655/
https://ncbi.nlm.nih.gov/pubmed/27536435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/21556660.2013.785413
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!